10x - TXG Company Long-Term Indebtedness

Brandmark of 10x Genomics Corp (TXG)

10x Genomics, Inc. (TXG) maintains its leadership in genome analysis through unique patents that curb the expansion of new startups. The market trend for long-term debt on the GURU.Markets platform stands at 0.06, while high switching costs for software and equipment create significant barriers for customers. The brand's impeccable authority within the scientific community solidifies the company's status as the industry benchmark.

TXG - 10x Genomics, Inc. Company Long-Term Debts over the range 07/04/2022 - 10/30/2026

Summary analytical data breakdowns for 10x Genomics Corp (TXG)

- current price and projected stock value:
Price 10xgenomics.com|TXG - Consensus Target
- issuer market value details:
Market Capitalization 10x Genomics|TXG - Real Price to Acquire Entire Company
- balance sheet net asset value indicators:
Accounting Value of a Share 10x Genomics|TXG - Book Capitalization|Market Value to Equity Ratio 10xgenomics.com|TXG - Company Total Assets
- company total debt and liquidity indicators:
Debt to Capital 10x Genomics, Inc.|TXG - Long-Term Debt to Equity|Short-Term Debt to Capital Ratio 10x|TXG - Company Debts|Debts to Book Value 10x Genomics|TXG - Company Long-Term Debt|Company Current Liabilities 10x Genomics|Interim Coverage Ratio 10xgenomics.com
- earnings and market ratios statistics:
TXG - Net Profit
Analysis of all company metrics:10x Genomics, Inc.
Manufactured product of 10xgenomics.com

This indicator aggregates total liabilities with maturities exceeding twelve months, allowing for an assessment of long-term creditworthiness and capital financing strategy. The stability of this metric confirms the ability of 10x Genomics, Inc. (TXG) to attract investment in highly skilled personnel and cutting-edge genetic research, which is clearly reflected in the firm's long-term debt statistics.

Competitors of 10x Genomics, Inc. (TXG)

Amount of Long-Term Liabilities TEM (Tempus Labs)|QGEN: Company Long-Term Liabilities|IONS (Ionis Pharmaceuticals, Inc.) - Company Long-Term Indebtedness|RGEN (Repligen Corp.) - Company Long-Term Liabilities|Avidity Corp - Company Long-Term Loans and Borrowings|CRSP (CRISPR Therapeutics AG) - Company Long-Term Debts|WGS - Long-Term Indebtedness|Company Long-Term Debts RARE|BEAM - Long-Term Debt|Company Long-Term Debt Sarepta Therapeutics Inc SRPT|TWST: Company Long-Term Indebtedness|NTLA - Company Long-Term Debt|Long-Term Debt stoketherapeutics.com|BioLife Solutions (BLFS) - Company Long-Term Debt|Company Long-Term Liabilities Wave Life Sciences Ltd|MAZE (Maze Tx) - Company Long-Term Debts|Sionna Corp (SION) - Long-Term Debt Volume|Company Long-Term Debts PRME|Company Long-Term Liabilities tayshagtx.com TSHA|Company Long-Term Debt uniQure QURE|Long-Term Debt Volume MeiraGTx Holdings (MGTX)|RGNX: Company Long-Term Liabilities|Company Long-Term Loans and Borrowings SLDB (Solid Corp)|OCGN: Company Long-Term Debts|PACB - Long-Term Debt Volume|Company Long-Term Debt Benitec Biopharma|Company Long-Term Indebtedness DSGN (Design Therapeutics Inc)|Company Long-Term Debts RCKT|Company Long-Term Liabilities 4D Molecular Corp FDMT|Lexeo Therapeutics, Inc. - Company Long-Term Liabilities|Long-Term Debt Volume Korro Bio Inc. (KRRO)|EDIT: Company Long-Term Liabilities|Silence Therapeutics PLC - Amount of Long-Term Liabilities|PRQR (proqr.com) - Company Long-Term Liabilities|Company Long-Term Indebtedness CDXS|SGMO (Sangamo Therapeutics) - Company Long-Term Debts|NAUT - Long-Term Indebtedness|Company Long-Term Debts MGX|Precision BioSciences Inc. - Company Long-Term Indebtedness|Company Long-Term Debt Generation Bio GBIO|BOLD: Company Long-Term Indebtedness|Exicure Corp - Company Long-Term Debts|IMNN - Company Long-Term Debts|PHIO: Company Long-Term Debts|MBIO: Amount of Long-Term Liabilities|Company Long-Term Liabilities RNAZ|Company Long-Term Indebtedness BNGO (Bionano)|Company Long-Term Liabilities APDN (Applied DNA Sciences)|BLUE (bluebirdbio.com) - Company Long-Term Loans and Borrowings|Company Long-Term Debts IPA (ImmunoPrecise Antibodies Ltd.)|Long-Term Indebtedness Omega Therapeutics Inc|Singular Genomics Systems Inc - Company Long-Term Debts|Long-Term Debt Regulus|Syros Pharmaceuticals (SYRS) - Company Long-Term Debt|Company Long-Term Indebtedness TBIO|Company Long-Term Debt TRACON Pharmaceuticals, Inc.|Long-Term Debt Unity Biotechnology Inc. UBX